STATCenter·
Opinion: The smart way to regulate the peptide boom
“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.
Read at STAT →
“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.

<iframe src="https://statesidedaily.com/embed/cluster/1a848d989bc07e2fa4d7f4dccc1e5f8ba2d26886" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Opinion: The smart way to regulate the peptide boom"></iframe>
